LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,738,524 | +113.8% | 45,703 | +157.3% | 0.00% | – |
| Q2 2023 | $1,280,640 | -78.1% | 17,762 | -77.6% | 0.00% | -100.0% |
| Q1 2023 | $5,837,501 | -46.1% | 79,357 | -51.1% | 0.00% | -50.0% |
| Q4 2022 | $10,830,150 | -36.8% | 162,128 | -18.5% | 0.00% | -33.3% |
| Q3 2022 | $17,125,000 | +1261.3% | 198,868 | +1310.4% | 0.00% | – |
| Q2 2022 | $1,258,000 | -25.3% | 14,100 | -5.7% | 0.00% | – |
| Q1 2022 | $1,683,000 | -59.2% | 14,960 | -44.0% | 0.00% | – |
| Q4 2021 | $4,127,000 | -35.9% | 26,719 | -42.2% | 0.00% | -100.0% |
| Q3 2021 | $6,435,000 | +41.6% | 46,201 | +33.3% | 0.00% | – |
| Q2 2021 | $4,546,000 | -75.6% | 34,658 | -71.7% | 0.00% | -100.0% |
| Q1 2021 | $18,662,000 | -38.1% | 122,421 | -59.6% | 0.00% | -50.0% |
| Q4 2020 | $30,154,000 | +19.6% | 303,211 | +14.6% | 0.01% | +14.3% |
| Q3 2020 | $25,215,000 | +48.6% | 264,538 | +74.4% | 0.01% | +16.7% |
| Q2 2020 | $16,965,000 | -12.4% | 151,677 | -43.0% | 0.01% | -25.0% |
| Q1 2020 | $19,367,000 | +5.4% | 266,330 | +51.2% | 0.01% | -11.1% |
| Q4 2019 | $18,375,000 | +6.2% | 176,189 | +1.3% | 0.01% | +12.5% |
| Q3 2019 | $17,306,000 | +35.0% | 173,864 | +54.8% | 0.01% | +33.3% |
| Q2 2019 | $12,820,000 | -54.8% | 112,310 | -50.3% | 0.01% | -57.1% |
| Q1 2019 | $28,392,000 | +35.6% | 225,849 | +46.4% | 0.01% | +27.3% |
| Q4 2018 | $20,938,000 | +34.1% | 154,292 | +171.3% | 0.01% | +57.1% |
| Q3 2018 | $15,610,000 | +18.6% | 56,871 | -10.5% | 0.01% | +16.7% |
| Q2 2018 | $13,160,000 | +102.2% | 63,520 | +61.2% | 0.01% | +100.0% |
| Q1 2018 | $6,510,000 | +204.1% | 39,414 | +152.0% | 0.00% | +200.0% |
| Q4 2017 | $2,141,000 | -4.6% | 15,642 | -5.1% | 0.00% | -50.0% |
| Q3 2017 | $2,244,000 | +46.7% | 16,482 | +30.8% | 0.00% | +100.0% |
| Q2 2017 | $1,530,000 | +72.1% | 12,600 | +50.0% | 0.00% | – |
| Q1 2017 | $889,000 | -48.4% | 8,400 | -50.5% | 0.00% | -100.0% |
| Q4 2016 | $1,724,000 | -39.8% | 16,966 | -39.5% | 0.00% | -50.0% |
| Q3 2016 | $2,862,000 | +1282.6% | 28,043 | +1372.1% | 0.00% | – |
| Q4 2015 | $207,000 | -25.3% | 1,905 | -30.6% | 0.00% | – |
| Q2 2015 | $277,000 | +2.2% | 2,744 | -22.0% | 0.00% | – |
| Q1 2015 | $271,000 | +11.1% | 3,516 | -23.4% | 0.00% | – |
| Q4 2014 | $244,000 | +73.0% | 4,588 | +52.7% | 0.00% | – |
| Q3 2014 | $141,000 | -19.0% | 3,004 | +7.7% | 0.00% | – |
| Q2 2014 | $174,000 | -91.8% | 2,790 | -91.2% | 0.00% | -100.0% |
| Q1 2014 | $2,122,000 | +759.1% | 31,560 | +571.9% | 0.00% | – |
| Q4 2013 | $247,000 | -85.5% | 4,697 | -88.1% | 0.00% | -100.0% |
| Q3 2013 | $1,704,000 | – | 39,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |